TAMPA, Fla. - Marpai, Inc. (NASDAQ:MRAI), a Third-Party Administration (TPA) company specializing in self-funded employer health plans, has announced the issuance of $11.83 million in convertible notes. The financing was provided by funds managed by JGB Management Inc. and is expected to strengthen Marpai's position in the health plan services market.
The three-year convertible notes come with a provision allowing conversion into Marpai's common stock at $3.00 per share, a premium over the current market price. Additionally, the notes include price protection should Marpai issue shares below this conversion price, with a floor of $2.23 per share.
According to Marpai's CEO, Damien Lamendola, the proceeds will be allocated to repaying existing debt to Libertas Funding, supporting the company's growth initiatives, and enhancing working capital. This move aims to leverage Marpai's recent growth, propelled by its technology platform and commitment to cost-effective healthcare solutions for self-funded employers.
Marpai's growth reflects the broader industry trend towards self-funded health plans, with the company poised to capitalize on increasing demand. The new financing is intended to support Marpai's trajectory in the competitive TPA sector, which serves a significant portion of the over $1 trillion in annual claims.
The securities issued in this transaction have not been registered under the Securities Act of 1933 and are subject to restrictions on their sale in the U.S. ThinkEquity acted as the financial advisor to Marpai for this financing deal.
The information provided in this article is based on a press release statement from Marpai, Inc. The company operates nationwide, offering access to major provider networks and a full range of TPA services. More information about Marpai can be found on their website, though it is not part of this news release.
It is important to note that the press release contains forward-looking statements that involve risks and uncertainties. These statements should not be seen as guarantees of future performance, and actual results may vary from these projections. Investors are advised to read Marpai's filings with the Securities and Exchange Commission for a more comprehensive understanding of the company and the risks involved.
InvestingPro Insights
In light of Marpai, Inc.'s (NASDAQ:MRAI) recent announcement regarding the issuance of convertible notes, current and prospective investors may find the following data and insights from InvestingPro valuable for assessing the company's financial health and market position:
InvestingPro Data reveals a market capitalization of $21.12 million, indicating the company's relative size in the sector. Despite a notable revenue growth of 52.64% over the last twelve months as of Q4 2023, Marpai's financials reflect some challenges.
The company has a negative P/E ratio of -0.77 for the same period, suggesting that it is not currently profitable. Additionally, the operating income margin stands at a concerning -70.98%, highlighting the company's difficulties in managing operational costs relative to its revenue.
InvestingPro Tips underscore the importance of liquidity and profitability for investors. Marpai may be facing difficulties with short-term obligations, as they exceed liquid assets. This could raise concerns about the company's ability to meet its immediate financial liabilities. Furthermore, analysts do not expect Marpai to be profitable this year, which could impact investor sentiment and stock performance.
For those considering a deeper dive into Marpai's financials and future outlook, InvestingPro offers an array of additional tips. Currently, there are 15 more InvestingPro Tips available for Marpai, Inc., accessible through the dedicated page at https://www.investing.com/pro/MRAI. To get the most comprehensive analysis, use the coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.